| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_180a89049fd37a008b5c86e9d727c730 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 |
| filingDate |
2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f137815d456cdc438acd85ecad4ad57e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e1fd31fe9b62b4ab08181c6d508426e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1ff1c1e22ce2d7a3d31bcc192746efe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4495b2a5a9ca5df2400513a6057f36d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c278c7ac9f72f691c4282127f50538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9a7d84aa8a7f1121a0e371089de8e9c |
| publicationDate |
2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109715201-A |
| titleOfInvention |
Use of IL-13 antagonists for the treatment of atopic dermatitis |
| abstract |
Use of an IL-13 antagonist for the treatment of atopic dermatitis is provided. Also provided are methods of treating atopic dermatitis and methods of reducing the severity of atopic dermatitis by administering an IL-13 antagonist. |
| priorityDate |
2016-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |